Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 111 composition records across product categories including Personal care.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of DEXTRAN 40 in our catalog (epa_cpdat).
Products
111
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 111 composition records across product categories including Personal care. EPA CPDat classifies this chemical for functional uses including Viscosity modifier, Binder, Filler.
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 300 mg
US
FDA
FDA NDC lists this ingredient in 2 active drug products and 2 total products.
US
FDA
FDA NDC lists this ingredient in 34 active drug products and 35 total products.
US
FDA
openFDA substance registry classifies this ingredient as polymer.